Coria Laboratories Report issue

For profit Phase 2
Founded: Aliso Vieja CA United States (2007)
Status: Acquired by Bausch Health Companies (2008)

Organization Overview

First Clinical Trial
2008
NCT00603772
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Coria Laboratories, Ltd.

Active Ingredients

Drugs in Phase 2 Trials (1)

tretinoin (Retin-A) (3 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dermatitis, Photoallergic (Phase 1)

Rosacea (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 1